Deviations from Standard Disk Diffusion Protocols for Antimicrobial Susceptibility Testing in Medical Laboratories in Gharyan
DOI:
https://doi.org/10.69667/lmj.2517411Keywords:
Deviations, Standard Disk Diffusion, Protocols, Antimicrobial Susceptibility Testing, Medical Laboratories.Abstract
Antimicrobial susceptibility testing (AST) is essential for guiding appropriate antibiotic therapy. The disk diffusion method is widely used in Libya due to its low cost, yet deviations from standardized protocols can compromise result accuracy, affecting clinical decisions and patient outcomes. This study evaluated the performance of the disk diffusion AST method in medical laboratories in Gharyan, Libya, using EUCAST guidelines (version 12.0) as a benchmark. Seventy-five AST plates representing 122 clinical specimens were randomly collected from three pathology centers between September and November 2025. Plates were analyzed for the type of culture media, number of specimens per plate, number of antibiotic disks, and readability of results. All plates were 90 mm in diameter. Nutrient agar was used for 118 specimens, and blood agar for two; none used Mueller-Hinton agar as recommended. Only 17% of plates tested a single specimen per plate; the majority tested one specimen on half or a quarter of a plate. The number of antibiotic disks per specimen often exceeded EUCAST limits (up to 20 disks per plate), and only 8% of plates yielded readable results. Widespread deviations from EUCAST protocols—including inappropriate media, specimen overloading, and excessive disks—compromise AST reliability. These errors may lead to incorrect antibiotic prescriptions, delayed recovery, and increased antimicrobial resistance. Strict adherence to standardized guidelines is urgently required to ensure accurate, clinically meaningful AST results. Moreover, raising awareness of the importance of following standard guidelines is crucial for correcting the course.
References
Sánchez-Romero MI, García-Lechuz Moya JM, González López JJ, Orta Mira N. Collection, transport and general processing of clinical specimens in Microbiology laboratory. Enferm Infecc Microbiol Clin (Engl Ed). 2019 Feb;37(2):127-134.
Chen C, Hong W. Recent development of rapid antimicrobial susceptibility testing methods through metabolic profiling of bacteria. Antibiotics (Basel). 2021 Mar 16;10(3):311.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. 14th ed. CLSI standard M02. Wayne, PA: Clinical and Laboratory Standards Institute; 2024.
The European Committee on Antimicrobial Susceptibility Testing. EUCAST disk diffusion method for antimicrobial susceptibility testing. Version 13.0. 2025. Available from: https://www.eucast.org/fileadmin/eucast/pdf/disk_test_documents/2025/Manual_v_13.0_EUCAST_Disk_Test_2025.pdf
BSAC. BSAC methods for antimicrobial susceptibility testing. Version 12. 2013. Available from: https://bsac.org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013_final.pdf
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. 2025. Available from: https://www.eucast.org
Mouton JW, Ambrose PG, Canton R, Drusano GL, Harbarth S, MacGowan A, et al. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat. 2011 Apr;14(2):107-17.
Mouton JW, Brown DF, Apfalter P, Cantón R, Giske CG, Ivanova M, et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect. 2012 Mar;18(3):E37-45.
Shrestha B, Rana SS. D test: a simple test with big implications for Staphylococcus aureus macrolide-lincosamide-streptogramin B resistance pattern. Nepal Med Coll J. 2014 Mar;16(1):88-94.





